Currently, there are 474.16M common shares owned by the public and among those 430.68M shares have been available to trade.
Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, accounting for 2,553,969 shares. Insider sales of the common stock occurred on 120 occasions, with total insider shares sold totaling 30,879,994 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The company’s stock has a 5-day price change of -11.38% and 32.33% over the past three months. PATH shares are trading -4.11% year to date (YTD), with the 12-month market performance up to 48.32% higher. It has a 12-month low price of $12.38 and touched a high of $27.87 over the same period. PATH has an average intraday trading volume of 10.67 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.98%, -0.67%, and 28.13% respectively.
Institutional ownership of UiPath Inc (NYSE: PATH) shares accounts for 58.07% of the company’s 474.16M shares outstanding.
It has a market capitalization of $13.48B and a beta (3y monthly) value of 0.99. The earnings-per-share (ttm) stands at -$0.27. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.77% over the week and 4.63% over the month.
Analysts forecast that UiPath Inc (PATH) will achieve an EPS of $COMPASS Pathways Plc – American for the current quarter, $10.17 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Bio-Path Holdings, Inc. while analysts give the company a high EPS estimate of $Patrick Industries, Inc.. Comparatively, EPS for the current quarter was $Pathward Financial, Inc. a year ago. Earnings per share for the fiscal year are expected to increase by 238.94%, and 11.87% over the next financial year. EPS should grow at an annualized rate of 46.20% over the next five years, compared to -4.42% over the past 5-year period.
Wells Fargo coverage for the UiPath Inc (PATH) stock in a research note released on June 09, 2023 offered a Equal Weight rating with a price target of $20. DA Davidson was of a view on April 21, 2023 that the stock is Neutral, while Canaccord Genuity gave the stock Buy rating on March 16, 2023, issuing a price target of $14.50- $19. Oppenheimer on their part issued Perform rating on November 03, 2022.
